125 related articles for article (PubMed ID: 24579680)
21. Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.
Kubek DJ; Burr DB; Allen MR
Orthod Craniofac Res; 2010 Nov; 13(4):214-22. PubMed ID: 21040464
[TBL] [Abstract][Full Text] [Related]
22. The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegration of dental implants in the rabbit maxilla.
Kim I; Ki H; Lee W; Kim H; Park JB
Int J Oral Maxillofac Implants; 2013; 28(5):1194-200. PubMed ID: 24066308
[TBL] [Abstract][Full Text] [Related]
23. Site specific effects of zoledronic acid during tibial and mandibular fracture repair.
Yu YY; Lieu S; Hu D; Miclau T; Colnot C
PLoS One; 2012; 7(2):e31771. PubMed ID: 22359627
[TBL] [Abstract][Full Text] [Related]
24. Bone-site-specific responses to zoledronic acid.
Vermeer J; Renders G; van Duin MA; Jansen I; Bakker LF; Kroon SA; de Vries TJ; Everts V
Oral Dis; 2017 Jan; 23(1):126-133. PubMed ID: 27706930
[TBL] [Abstract][Full Text] [Related]
25. Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute.
Välimäki VV; Moritz N; Yrjans JJ; Vuorio E; Aro HT
Bone; 2006 Mar; 38(3):432-43. PubMed ID: 16338190
[TBL] [Abstract][Full Text] [Related]
26. Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats.
Li CL; Lu WW; Seneviratne CJ; Leung WK; Zwahlen RA; Zheng LW
Clin Oral Implants Res; 2016 Jan; 27(1):1-6. PubMed ID: 25371026
[TBL] [Abstract][Full Text] [Related]
27. Effect of zoledronic acid in an L6-L7 rabbit spine fusion model.
Bransford R; Goergens E; Briody J; Amanat N; Cree A; Little D
Eur Spine J; 2007 Apr; 16(4):557-62. PubMed ID: 16967298
[TBL] [Abstract][Full Text] [Related]
28. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.
Little DG; Peat RA; Mcevoy A; Williams PR; Smith EJ; Baldock PA
J Bone Miner Res; 2003 Nov; 18(11):2016-22. PubMed ID: 14606515
[TBL] [Abstract][Full Text] [Related]
29. Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits.
Smith EJ; Little DG; Briody JN; McEvoy A; Smith NC; Eisman JA; Gardiner EM
J Bone Miner Res; 2005 Oct; 20(10):1731-41. PubMed ID: 16160731
[TBL] [Abstract][Full Text] [Related]
30. Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect.
Olejnik C; Falgayrac G; During A; Cortet B; Penel G
Bone; 2016 Aug; 89():32-39. PubMed ID: 27168397
[TBL] [Abstract][Full Text] [Related]
31. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
[TBL] [Abstract][Full Text] [Related]
32. Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.
Li X; Liao J; Park SI; Koh AJ; Sadler WD; Pienta KJ; Rosol TJ; McCauley LK
Bone; 2011 Jun; 48(6):1354-61. PubMed ID: 21419883
[TBL] [Abstract][Full Text] [Related]
33. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches.
Soki FN; Li X; Berry J; Koh A; Sinder BP; Qian X; Kozloff KM; Taichman RS; McCauley LK
J Cell Biochem; 2013 Jan; 114(1):67-78. PubMed ID: 22833499
[TBL] [Abstract][Full Text] [Related]
34. Jaw bone changes in rats after treatment with zoledronate and pamidronate.
Senel FC; Kadioglu Duman M; Muci E; Cankaya M; Pampu AA; Ersoz S; Gunhan O
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):385-91. PubMed ID: 20060339
[TBL] [Abstract][Full Text] [Related]
35. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model.
Çankaya M; Cizmeci Şenel F; Kadioglu Duman M; Muci E; Dayisoylu EH; Balaban F
Int J Oral Maxillofac Surg; 2013 Sep; 42(9):1134-9. PubMed ID: 23522850
[TBL] [Abstract][Full Text] [Related]
36. Histological and biomechanical effects of zoledronate on fracture healing in an osteoporotic rat tibia model.
Türker M; Aslan A; Çırpar M; Kochai A; Tulmaç ÖB; Balcı M
Eklem Hastalik Cerrahisi; 2016; 27(1):9-15. PubMed ID: 26874629
[TBL] [Abstract][Full Text] [Related]
37. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
[TBL] [Abstract][Full Text] [Related]
38. Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis.
Pampu AA; Dolanmaz D; Tüz HH; Karabacakoglu A
J Oral Maxillofac Surg; 2006 Aug; 64(8):1232-6. PubMed ID: 16860215
[TBL] [Abstract][Full Text] [Related]
39. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
Amanat N; McDonald M; Godfrey C; Bilston L; Little D
J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160
[TBL] [Abstract][Full Text] [Related]
40. Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial.
Huang TW; Wang CJ; Shih HN; Chang Y; Huang KC; Peng KT; Lee MS
BMC Musculoskelet Disord; 2017 May; 18(1):209. PubMed ID: 28532408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
